A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial.
Gholamreza Toogeh(Imam Khomeini Hospital), Shadi Sadat Alizadeh Fard(Shahid Beheshti University of Medical Sciences), Ehsan Rezaei‐Darzi(Tehran University of Medical Sciences), Abolghasem Allahyari(Mashhad University of Medical Sciences), Vahid Fallahazad(Mahak Hospital and Rehabilitation Complex), Mohammad Faranoush(Iran University of Medical Sciences), Seyed Mohsen Razavi(Firoozgar General Hospital), Fariba Zarrabi(Tehran University of Medical Sciences), Hassan Jalaeikhoo(Aja University of Medical Sciences), Mohammad Reza Ravanbod(Bushehr University of Medical Sciences)
PubMed
April 1, 2018
Cited by 17
Related Papers
Overexpression of Orphan Receptor Tyrosine Kinase <i>Ror1</i> as a Putative Tumor-Associated Antigen in Iranian Patients with Acute Lymphoblastic Leukemia
|Tumor Biology|2007|46
Expression profile of orphan receptor tyrosine kinase (<i>ROR1</i>) and Wilms' tumor gene 1 (<i>WT1</i>) in different subsets of B-cell acute lymphoblastic leukemia
|Leukemia & lymphoma/Leukemia and lymphoma|2008|46
The Prognostic Value of Thrombocytopenia in COVID-19 Patients; a Systematic Review and Meta-Analysis.
|PubMed|2020|45
Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin
|Biomedicine & Pharmacotherapy|2017|31
Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura
|The Indian Journal of Pediatrics|2008|30